Journals

BROGYANYI, T., R. KAPLANEK, Z. KEJIK, B. HOSNEDLOVA, V. ANTONYOVA, N. ABRAMENKO, K. VESELA, P. MARTASEK, M. VOKURKA, D. RICHARDSON, M. JAKUBEK
Azulene hydrazide-hydrazones for selective targeting of pancreatic cancer cells. Biomedicine & Pharmacotherapy. 2022, 155, 113736, ISSN: 0753-3322, PMID: 36156366,
KRECMEROVA, M.
Od 5-azapyrimidinové chemie k thiadiazolům. Chemicke Listy. 2022, 116, 152-162, ISSN: 0009-2770,
ANDREI, G., P. FITEN, M. KRECMEROVA, G. OBDENAKKER, D. TOPALIS, R. SNOECK
Poxviruses Bearing DNA Polymerase Mutations Show Complex Patterns of Cross-Resistance. Biomedicines. 2022, 1(10), 580, ISSN: 2227-9059, PMID: 35327382,
KRECMEROVA, M., P. MAJER, R. RAIS, B. SLUSHER
Phosphonates and Phosphonate Prodrugs in Medicinal Chemistry: Past Successes and Future Prospects. Frontiers in Chemistry. 2022, 20(10), 889737, ISSN: 2296-2646, PMID: 35668826,
NAUŠ, P., O. CALETKOVÁ, P. PERLÍKOVÁ, L. SLAVĚTÍNSKÁ, E. TLOUŠŤOVÁ, J. HODEK, J. WEBER, P. DŽUBÁK, M. HAJDÚCH, M. HOCEK
Synthesis and biological profiling of 6-or 7-(het)aryl-7-deazapurine 4 '-C-methylribonucleosides. Bioorganic and Medicinal Chemistry. 2015, 23(23), 7422-7438, ISSN: 0968-0896, PMID: 26558518,
BUSEK, P., J. DUKE-COHAN, A. SEDO
Does DPP-IV Inhibition Offer New Avenues for Therapeutic Intervention in Malignant Disease?. Cancers. 2022, 14(9), 2072, ISSN: 2072-6694, PMID: 35565202,
ARPAS, T., H. JELINKOVA, S. HRABOVSKY, M. ORSULOVA, Z. VRZALOVA, V. NAVRKALOVA, E. BRHELOVA, L. BRYJOVA, A. BULIKOVA, E. ONDOUSKOVA, M. SEJNOHOVA, F. FOLBER, P. SEDOVA, J. MAYER, S. POSPISILOVA, M. JAROSOVA, M. DOUBEK
Very rare near-haploid acute lymphoblastic leukemia resistant to immunotherapy and CAR-T therapy in 19-year-old male patient. Clinical Case Reports. 2022, 10(3), e05545, ISSN: 2050-0904, PMID: 35280086,
OLBERTOVA, H., K. PLEVOVA, S. PAVLOVA, J. MALCIKOVA, J. KOTASKOVA, K. STRANSKA, M. SPUNAROVA, M. TRBUSEK, V. NAVRKALOVA, B. DVORACKOVA, N. TOM, K. PAL, M. JAROSOVA, Y. BRYCHTOVA, A. PANOVSKA, M. DOUBEK, S. POSPISILOVA
Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes. BMC Cancer. 2022, 22(1), 137, ISSN: 1471-2407, PMID: 35114947,
ZHANG, Y., T. BLOMQUIST, R. KUSKO, D. STETSON, Z. ZHANG, L. YIN, R. SEBRA, B. GONG, J. LOCOCO, V. MITTAL, N. NOVORADOVSKAYA, J. YEO, N. DOMINIAK, J. HIPP, A. RAYMOND, F. OIU, H. ARIB, M. SMITH, J. BROCK, D. FARKAS, D. CRAIG, E. CRAWFORD, D. LI, T. MORISSON, N. TOM, W. XIAO, M. YANG, C. MASON, T. RICHMOND, W. JONES, D. JOHANN JR., L. SHI, W. TONG, J. WILLEY, J. XU
Deep oncopanel sequencing reveals within block position-dependent quality degradation in FFPE processed samples. Genome Biology. 2022, 23(1), 141, ISSN: 1474-7596, PMID: 35768876,
KOLOUCHOVA, K., Z. CERNOCHOVA, O. GROBORZ, V. HERYNEK, F. KOUCKY, R. JAKSA, J. BENES, M. SLOUF
Multiresponsive fluorinated polymers as a theranostic platform using 19F MRI. European Polymer Journal. 2022, 175(2022), 111381, ISSN: 0014-3057,